Suppr超能文献

N末端B型利钠肽原对首次诊断或阵发性心房颤动患者到急诊科进行心脏复律短期结局的预测价值

Predictive Value of N-Terminal Pro B-Type Natriuretic Peptide for Short-Term Outcome of Cardioversion in Patients with First-Diagnosed or Paroxysmal Atrial Fibrillation Presenting to the Emergency Department.

作者信息

Diakantonis Antonios, Verras Christos, Bezati Sofia, Bistola Vasiliki, Ventoulis Ioannis, Velliou Maria, Boultadakis Antonios, Ikonomidis Ignatios, Parissis John T, Polyzogopoulou Effie

机构信息

University Department of Emergency Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece.

Second Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece.

出版信息

Biomedicines. 2024 Dec 19;12(12):2895. doi: 10.3390/biomedicines12122895.

Abstract

: Atrial fibrillation (AF) is a common arrhythmia in the emergency department (ED). We investigated the role of N-terminal pro b-type natriuretic peptide (NT-proBNP) in predicting both the outcome of AF cardioversion and the risk of AF recurrence or persistence on the 8th (D8) and 30th (D30) day post-cardioversion. : This prospective, observational study evaluated patients with recent-onset AF, managed by either pharmacological (PC) or electrical cardioversion (EC) in the ED. Patients were treated either immediately or electively after 3 weeks of anticoagulation. NT-proBNP assessments were performed prior to cardioversion. : Of the 148 patients enrolled, 56% had paroxysmal AF, 85% underwent immediate cardioversion and 72% received EC. Successful cardioversion to sinus rhythm (SR) was achieved in 85% of patients. Patients with successful cardioversion and those who remained free from AF on D8 had lower NT-proBNP levels compared to patients with failed cardioversion or with AF recurrence or persistence on D8 [day of cardioversion, D0: SR vs. non-SR, 387 (127-1095) pg/mL vs. 1262 (595-2295), = 0.004; D8: SR vs. non-SR, 370 (127-1095) vs. 1366 (718-2295), = 0.002]. In multivariate analysis, higher logNT-proBNP was associated with higher risk of cardioversion failure [OR, 95%CI: 4.80 (1.58-14.55), = 0.006] and AF recurrence or persistence on D8 [OR, 95%CI: 3.65 (1.06-12.59), = 0.041]. ROC analysis confirmed the predictive ability of NT-proBNP for both outcomes (D0: AUC 0.735, < 0.001; D8: AUC 0.761, < 0.001). A cut-off value of NT-proBNP > 580 pg/mL was able to predict failure of AF conversion and occurrence of recurrent/persistent AF at D8. : NT-proBNP is a promising biomarker for identifying patients presenting to the ED with recent-onset AF who run a greater risk of cardioversion failure and post-discharge AF recurrence/persistence in the immediate and short term.

摘要

心房颤动(AF)是急诊科常见的心律失常。我们研究了N末端B型利钠肽原(NT-proBNP)在预测房颤复律结果以及复律后第8天(D8)和第30天(D30)房颤复发或持续风险方面的作用。

这项前瞻性观察性研究评估了急诊科近期发生房颤且接受药物复律(PC)或电复律(EC)治疗的患者。患者在抗凝3周后立即或择期接受治疗。在复律前进行NT-proBNP评估。

在纳入的148例患者中,56%为阵发性房颤,85%接受了立即复律,72%接受了电复律。85%的患者成功复律为窦性心律(SR)。与复律失败或在D8时房颤复发或持续的患者相比,成功复律的患者以及在D8时未发生房颤的患者NT-proBNP水平较低[复律日,D0:SR与非SR,387(127 - 1095)pg/mL对1262(595 - 2295),P = 0.004;D8:SR与非SR,370(127 - 1095)对1366(718 - 2295),P = 0.002]。在多变量分析中,较高的logNT-proBNP与复律失败风险较高[比值比(OR),95%置信区间(CI):4.80(1.58 - 14.55),P = 0.006]以及D8时房颤复发或持续风险较高[OR,95%CI:3.65(1.06 - 12.59),P = 0.041]相关。受试者工作特征(ROC)分析证实了NT-proBNP对这两种结果的预测能力(D0:曲线下面积(AUC)0.735,P < 0.001;D8:AUC 0.761,P < 0.001)。NT-proBNP>580 pg/mL的临界值能够预测房颤转复失败以及D8时复发性/持续性房颤的发生。

NT-proBNP是一种有前景的生物标志物,可用于识别急诊科近期发生房颤且在即刻和短期内复律失败及出院后房颤复发/持续风险较高的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe17/11727096/8f2c5f2d7fac/biomedicines-12-02895-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验